Dr. Fulai Jin's lab focuses on understanding the three-dimensional structure of the genome and its role in gene regulation and disease, particularly how genetic variations influence DNA looping in cells. Using advanced techniques like Hi-C and deep learning, the lab investigates the intricate relationships between chromatin organization and gene expression, leveraging mouse models to draw insights relevant to human biology and diseases such as diabetes.

Dr. Berkley E. Gryder's lab at Case Western Reserve University studies advanced prostate cancer, focusing on understanding how the androgen receptor (AR) can be targeted to suppress cancer growth. They are developing innovative small molecule therapies that can switch the function of the AR from promoting tumor growth to inhibiting it. By exploring the molecular and epigenetic mechanisms involved, the lab aims to improve treatment strategies for patients with resistant forms of prostate cancer.

Dr. Yan Li's lab focuses on understanding pancreatic beta-cell biology and its implications for diabetes. They study how variations in genetic factors, particularly the gene HNF1A, affect the development and function of these cells. By using advanced techniques like single-cell genomic analyses, they aim to develop better strategies for generating functional beta-cells from stem cells, which could be crucial for diabetes therapies.

Dr. Robyn M. Busch's lab focuses on understanding memory problems in patients with temporal lobe epilepsy (TLE), especially those who continue to have seizures despite treatment. The lab aims to uncover the biological markers associated with memory issues to develop better treatments and preventive strategies. By studying tissue samples and blood from patients, the research is set to improve prognostic models and ultimately enhance the quality of life for individuals affected by TLE and related neurological disorders.

Dr. James Peter Basilion's research lab focuses on improving cancer treatment through innovative imaging and therapeutic techniques. By developing specialized agents that target cancer cells, they aim to enhance surgical precision while boosting the immune response to prevent recurrence and metastasis. Their work combines fluorescence-guided surgery with photodynamic and photothermal therapies to address unmet clinical needs in prostate and breast cancer treatments.

Dr. Julian Stelzer's research lab at Case Western Reserve University focuses on understanding genetic mutations in the cardiac myosin binding protein C (cMyBP-C) and how these mutations lead to hypertrophic cardiomyopathy (HCM), a condition that can cause heart failure. The lab combines molecular biology, biophysics, and computer modeling to study how specific mutations affect heart muscle function and to develop predictive tools for better treatment strategies. Their goal is to identify which genetic variants pose the greatest risk to patients and to improve clinical outcomes.

Dr. Zhenghe Wang's lab focuses on understanding the role of a specific gene known as PTPRT in the development and spread of colorectal cancer. They investigate how mutations in this gene disrupt normal cellular processes, resulting in cancer cell growth and metastasis. The lab aims to discover new therapeutic targets by exploring the mechanisms behind protein modifications that influence cancer progression.

Dr. Evan Deneris's lab at Case Western Reserve University focuses on understanding how different types of serotonin neurons develop in the brain. They use advanced techniques to examine how genes and regulatory mechanisms shape these neurons and how disruptions in these processes could lead to neurodevelopmental disorders, like autism and depression. The lab combines expertise in molecular biology, genomics, and neuroscience to unravel these complex questions.

Dr. Matthias Buck's lab at Case Western Reserve University focuses on the role of Eph receptors in cell signaling related to blood vessel formation and neurological diseases like Alzheimer's. His research aims to uncover the molecular mechanisms behind Eph receptor interactions, particularly how these proteins affect the integrity of the blood-brain barrier. This work is significant because understanding these mechanisms can contribute to developing new diagnostic tools and therapies for neurodegenerative and vascular diseases.

Dr. Ahmet Erdemir's lab focuses on improving the accuracy and consistency of knee biomechanics simulations. They work on developing standardized modeling workflows to ensure that simulations can reliably predict knee mechanics, which is important for understanding musculoskeletal diseases and improving surgical outcomes. The research aims to make computational models more accessible and reproducible, which can ultimately help in clinical decision-making and personalized medicine for patients with knee issues.

Dr. Agata Exner's research focuses on enhancing cancer diagnosis and treatment using innovative ultrasound technologies. By developing specialized nanoparticles called nanobubbles, her lab aims to improve prostate cancer biopsy accuracy and predict how well tumors will respond to nanoparticle-based chemotherapy. This work seeks to revolutionize personalized cancer therapy by providing real-time imaging methods to guide treatment decisions.

Dr. Norah C. Feeny's lab focuses on understanding and improving psychological treatments for conditions like PTSD and depression, particularly in how individuals process stressful life events. The lab aims to develop innovative therapies that not only address negative emotional responses but also promote resilience and positive coping strategies. This research is vital because many existing treatments have high dropout rates and may not fully meet the needs of individuals suffering from these disorders.

Dr. Christopher Flask's lab focuses on improving cancer diagnosis and treatment monitoring using advanced MRI techniques. By developing innovative methods such as Magnetic Resonance Fingerprinting (MRF), they aim to better measure tumor blood flow and acidity. Their research highlights the potential for these techniques to be translated into clinical settings for more effective cancer therapies.

Dr. Tingwei Mu's lab focuses on understanding how misfolding of GABAA receptors leads to genetic epilepsies, which are caused by the loss of function in these crucial proteins. The lab investigates how these receptors are properly folded and trafficked to the cell membrane, as errors in this process can contribute to severe neurological disorders. The ultimate goal is to find new therapeutic strategies to correct the function of misfolded receptors in patients with epilepsy.

Dr. Brian A. Cobb's lab at Case Western Reserve University studies the complex world of glycoproteins, especially how their sugar structures influence immune responses. The team's research focuses on how glycosylation (the addition of sugar molecules to proteins), particularly on antibodies, can be modulated for therapeutic benefits in diseases like autoimmunity and inflammation. By understanding the mechanisms behind these modifications, the lab aims to create new treatments that can better manage inflammatory diseases through targeted therapies.

Dr. William Grissom's lab focuses on developing innovative techniques for prostate cancer surgery to reduce complications associated with traditional invasive procedures. By integrating low-field MRI with a specialized robotic system, the lab aims to create a minimally invasive approach that allows surgeons to precisely target and remove cancerous tissue while preserving healthy tissue. This research can potentially revolutionize the treatment of prostate cancer, enhancing patient outcomes and quality of life.

The research lab of Dr. Shuo Li focuses on improving the prediction and management of heart failure through advanced imaging techniques. By analyzing non-contrast low-dose CT scans, the lab aims to develop machine learning models that can identify individuals at high risk of heart failure. The lab's work combines innovative radiomics with clinical health assessments, seeking to enhance preventive strategies and ensure more personalized patient care.

Dr. Jonathan Karn's lab at Case Western Reserve University focuses on understanding how HIV persists in the body, particularly in the brain, and how different factors, such as RNA modifications and substance use, influence this process. The lab works to develop new methods for studying HIV latency and reactivation using advanced techniques such as next-generation sequencing and induced pluripotent stem cells. By deciphering the complex interactions between HIV and the brain, the lab aims to contribute to better treatments for HIV-associated neurocognitive disorders.

Dr. Sudha Chakrapani's lab focuses on understanding the molecular workings of specific ion channels in the brain that are crucial for fast communication between nerve cells. By studying these channels, which play roles in vital bodily functions like movement and pain perception, the lab aims to find new ways to develop drugs that can effectively treat neurological disorders and chronic pain. They use advanced techniques to visualize these channels and determine how they are regulated in the body.

Dr. Maria Hatzoglou's lab focuses on how cells adapt to stress, specifically dehydration, by regulating protein synthesis. This research is important for understanding and treating diseases like diabetes and dry eye syndrome, which are linked to problems with cellular responses to stress. By studying how cells adjust their internal processes during dehydration, the lab aims to uncover new therapeutic strategies to improve cell survival in various health conditions.